Homebiopharmaceutical

biopharmaceutical

BLRX NOTICE: ROSEN, GLOBALLY RESPECTED INVESTOR COUNSEL, Encourages BioLineRx Ltd. Investors to Inquire About Securities Class Action Investigation – BLRX

BLRX NOTICE: ROSEN, GLOBALLY RESPECTED INVESTOR COUNSEL, Encourages BioLineRx Ltd. Investors to Inquire About Securities Class Action Investigation – BLRX

January 1, 2023

EYEPOINT INVESTOR ALERT: Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $50,000 In Eyepoint To Contact Him Directly To Discuss Their Options

EYEPOINT INVESTOR ALERT: Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $50,000 In Eyepoint To Contact Him Directly To Discuss Their Options

January 1, 2023

ROSEN, A LEADING AND LONGSTANDING FIRM, Encourages Eiger BioPharmaceuticals, Inc. Investors to Secure Counsel Before Important January 9 Deadline in Securities Class Action – EIGR

ROSEN, A LEADING AND LONGSTANDING FIRM, Encourages Eiger BioPharmaceuticals, Inc. Investors to Secure Counsel Before Important January 9 Deadline in Securities Class Action – EIGR

December 31, 2022

BLRX SHAREHOLDER ALERT: ROSEN, A GLOBAL AND LEADING LAW FIRM, Encourages BioLineRx Ltd. Investors to Inquire About Securities Class Action Investigation – BLRX

BLRX SHAREHOLDER ALERT: ROSEN, A GLOBAL AND LEADING LAW FIRM, Encourages BioLineRx Ltd. Investors to Inquire About Securities Class Action Investigation – BLRX

December 30, 2022

ROSEN, LEADING TRIAL ATTORNEYS, Encourages Eiger BioPharmaceuticals, Inc. Investors with Losses to Secure Counsel Before Important January 9 Deadline in Securities Class Action – EIGR

ROSEN, LEADING TRIAL ATTORNEYS, Encourages Eiger BioPharmaceuticals, Inc. Investors with Losses to Secure Counsel Before Important January 9 Deadline in Securities Class Action – EIGR

December 30, 2022

CLASS ACTION UPDATE for SEDG, EIGR and CURV: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders

CLASS ACTION UPDATE for SEDG, EIGR and CURV: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders

December 30, 2022

OTC Markets Group Grants Evofem Additional Time to File Quarterly Report on Form 10-Q for the Quarter Ended September 30, 2022

OTC Markets Group Grants Evofem Additional Time to File Quarterly Report on Form 10-Q for the Quarter Ended September 30, 2022

December 29, 2022

SHAREHOLDER ALERT: Rigrodsky Law, P.A. Is Investigating Catalyst Biosciences, Inc. Merger

SHAREHOLDER ALERT: Rigrodsky Law, P.A. Is Investigating Catalyst Biosciences, Inc. Merger

December 29, 2022

What Makes Aileron Therapeutics, Inc. (ALRN) a New Buy Stock

What Makes Aileron Therapeutics, Inc. (ALRN) a New Buy Stock

December 29, 2022

Biotech Stock Roundup: GILD’s HIV Drug Approval, PRQR Surges on LLY Deal & More

Biotech Stock Roundup: GILD’s HIV Drug Approval, PRQR Surges on LLY Deal & More

December 29, 2022

« 1 … 3 4 5 6 7 … 558 »